Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study

INTRODUCTION: Although tamoxifen (TAM) plus ovarian function suppression (OFS) is considered as a standard adjuvant treatment for premenopausal women with hormone receptor-positive breast cancer, the optimal duration of OFS has not yet been established. This retrospective study was designed to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozaki, Yukinori, Tanabe, Yuko, Tamura, Nobuko, Ogura, Takuya, Kondoh, Chihiro, Miura, Yuji, Yoshimura, Kenichi, Kawabata, Hidetaka, Takano, Toshimi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906507/
https://www.ncbi.nlm.nih.gov/pubmed/29357022
http://dx.doi.org/10.1007/s12282-018-0836-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906507/
https://www.ncbi.nlm.nih.gov/pubmed/29357022
http://dx.doi.org/10.1007/s12282-018-0836-x

Ejemplares similares